Vontobel Holding Ltd. Invests $388,000 in Bruker Co. (NASDAQ:BRKR)

Vontobel Holding Ltd. purchased a new position in Bruker Co. (NASDAQ:BRKR - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 6,614 shares of the medical research company's stock, valued at approximately $388,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Stanley Laman Group Ltd. acquired a new stake in Bruker during the 4th quarter worth about $5,229,000. Van ECK Associates Corp raised its holdings in Bruker by 48.8% during the 4th quarter. Van ECK Associates Corp now owns 84,004 shares of the medical research company's stock worth $4,924,000 after buying an additional 27,553 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in Bruker by 1.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 214,580 shares of the medical research company's stock worth $12,619,000 after buying an additional 3,819 shares during the period. Savant Capital LLC raised its holdings in Bruker by 44.9% during the 4th quarter. Savant Capital LLC now owns 26,440 shares of the medical research company's stock worth $1,550,000 after buying an additional 8,198 shares during the period. Finally, Vaughan Nelson Investment Management L.P. raised its holdings in Bruker by 140.3% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 1,141,762 shares of the medical research company's stock worth $66,930,000 after buying an additional 666,617 shares during the period. 79.52% of the stock is currently owned by institutional investors.

Bruker Price Performance

Bruker stock traded down $2.10 during mid-day trading on Friday, hitting $50.82. 2,050,917 shares of the company were exchanged, compared to its average volume of 1,650,530. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The business has a fifty day moving average of $56.87 and a 200 day moving average of $60.13. Bruker Co. has a 1-year low of $48.07 and a 1-year high of $94.86. The company has a market capitalization of $7.70 billion, a PE ratio of 66.87, a price-to-earnings-growth ratio of 2.10 and a beta of 1.16.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. As a group, sell-side analysts expect that Bruker Co. will post 2.69 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on BRKR shares. Barclays cut their price objective on Bruker from $69.00 to $65.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. Guggenheim reaffirmed a "buy" rating on shares of Bruker in a research note on Friday, January 17th. Stifel Nicolaus lowered their target price on Bruker from $70.00 to $57.00 and set a "hold" rating on the stock in a research note on Friday, February 14th. TD Cowen decreased their target price on Bruker from $72.00 to $70.00 and set a "hold" rating for the company in a research report on Wednesday, November 6th. Finally, UBS Group started coverage on Bruker in a research report on Tuesday, December 10th. They set a "neutral" rating and a $66.00 target price for the company. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, Bruker currently has a consensus rating of "Moderate Buy" and an average price target of $70.50.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.